Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...

Cardiomyopathy II: Dilated Cardiomyopathy

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

Cardiomyopathy IV: Restrictive Cardiomyopathy

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...

Cardiomyopathy V: Interprofessional Care

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

Cardiomyopathy VI: Nursing Management

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Beta-Blocker-Related Atrioventricular Conduction Disorders-A Single Tertiary Referral Center Experience.

Medicina (Kaunas, Lithuania)·2022

Same author

Evaluation of Laboratory Predictors for In-Hospital Mortality in Infective Endocarditis and Negative Blood Culture Pattern Characteristics.

Pathogens (Basel, Switzerland)·2021

Same author

Heart rate variability analysis and cardiac dysautonomia in ischemic stroke patients.

Clinical neurology and neurosurgery·2019

Same author

Inflammatory and Genetic Markers (APO B100 and Angiotensin-Converting Enzyme Gene) in the Coronary Artery Disease.

Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi·2018

Same author

Romanian Registry of Hypertrophic Cardiomyopathy - overview of general characteristics and therapeutic choices at a national level.

Romanian journal of internal medicine = Revue roumaine de medecine interne·2018

Same author

Linear and nonlinear parameters of heart rate variability in ischemic stroke patients.

Neurologia i neurochirurgia polska·2017

Search research articles

Related Experiment Video

Updated: May 17, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

[Takotsubo cardiomyopathy].

L Macovei¹, Geanina Coadă, V Constantinescu

¹Institutul de Boli Cardiovasculare "Prof. Dr. George I.M. Georgescu", Clinica de Cardiologie Medicală, Iaşi.

Revista Medico-Chirurgicala a Societatii De Medici Si Naturalisti Din Iasi

|October 20, 2012

Summary

Takotsubo cardiomyopathy, or "broken heart syndrome," is a temporary heart condition often affecting older women. Diagnosis is key to differentiate it from heart attacks, ensuring appropriate management and good prognosis.

More Related Videos

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

Isolation and Physiological Analysis of Mouse Cardiomyocytes

Isolation and Physiological Analysis of Mouse Cardiomyocytes

Published on: September 7, 2014

Related Experiment Videos

Last Updated: May 17, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

Isolation and Physiological Analysis of Mouse Cardiomyocytes

Isolation and Physiological Analysis of Mouse Cardiomyocytes

Published on: September 7, 2014

Area of Science:

Cardiology
Internal Medicine

Context:

Takotsubo cardiomyopathy (TTC) is an increasingly recognized cardiac syndrome.
It predominantly affects postmenopausal women and mimics acute myocardial infarction.

Purpose:

To present four cases of Takotsubo cardiomyopathy managed at the Cardiology Clinic of Cardiovascular Diseases Institute, Iasi.
To highlight the diagnostic challenges and clinical peculiarities differentiating TTC from acute myocardial infarction.

Summary:

TTC is characterized by transient left ventricular apical ballooning with normal coronary arteries.
ECG changes include ST-segment elevation and T-wave inversion; symptoms resemble myocardial infarction.
Pathophysiology is linked to catecholamine surge, causing myocardial stunning; treatment lacks standardization, but beta-agonist use is cautioned.

Impact:

Accurate diagnosis is crucial for appropriate management and differentiating TTC from acute myocardial infarction.
Understanding TTC's unique features improves patient outcomes, as prognosis is generally favorable with low mortality.
Recognizing rare complications like pulmonary edema and cardiogenic shock is vital for timely intervention.